Icon Cancer Foundation releases inaugural Impact Report

Icon Cancer Foundation (ICF) has released its inaugural Impact Report for 2024/25, celebrating the generosity of donors and the research achievements made possible through philanthropy.

Icon Cancer Foundation Chair Dr Jonathan Ramsay says the past 12 months have been a period of significant growth for the charity.

“We launched our inaugural research grants program and funded a diverse range of promising new projects, many aimed at improving quality of life for people living with cancer or chronic illness,” Dr Ramsay said.

“We also deepened our collaboration with clinicians across Icon Cancer Centre, ensuring our research was guided by those on the front line of care.”

Report highlights include:

• 266 patients on ICF-funded trials
• 45 new patients recruited
• Expansion of a prostate cancer study to Western Australia
• Launch of ICF’s inaugural research grant program
• Funding a key research position in cellular therapy
• Funding of 4 new investigator initiated studies opening FY25/26

This type of research is vital to improving patient outcomes and, with cancer rates continuing to rise, it’s more important than ever.

Over the next 20 years, cancer rates in Australia are expected to rise by 50 percent, and nearly two in five Australians will be diagnosed with cancer by the age of 85.

“Thank you to our supporters for making this work possible. Your generosity helps us invest in research delivering real impact for people with cancer, today and into the future,” Dr Ramsay said.